Trial intelligence / Profile preview

Envarsus XR and TransMedAx App in Kidney Transplant Recipients

NCT04711291Withdrawn

Sponsor
Beth Israel Deaconess Medical Center
Start
Jun 2017
Primary completion
Dec 2022
01

Overview

Randomised, open-label trial of tacrolimus in kidney transplantation, sponsored by Beth Israel Deaconess Medical Center. Planned start Jun 2017; status: withdrawn.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT04711291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04711291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call